Filing Details
X4 Pharmaceuticals, Inc (NASDAQ:XFOR) filed a Form 8-K with the Securities and Exchange Commission on October 08, 2026, disclosing a material event.
8k filedNASDAQ:XFOR
X4 Pharmaceuticals, Inc (XFOR) Reports Material Event to SEC
X4 Pharmaceuticals, Inc (NASDAQ:XFOR) filed a Form 8-K with the Securities and Exchange Commission on October 08, 2026, disclosing a material event.
At publication ·
What changed
X4 Pharmaceuticals, Inc (NASDAQ:XFOR) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- X4 Pharmaceuticals filed a Form 8-K on October 8, 2026, disclosing a material event to shareholders.
- The company's stock trades at $2.79 with a market capitalization of $44.2 million.
- Form 8-K filings report significant events such as leadership changes, agreements, acquisitions, or asset sales between regular reports.
Market Context
X4 Pharmaceuticals, Inc's stock currently trades at $2.79 with a market capitalization of $44.2M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for X4 Pharmaceuticals, Inc's stock.
All SEC filings for X4 Pharmaceuticals, Inc are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View XFOR Stock Page
Frequently Asked Questions
Where can I read XFOR's SEC filings?
Browse all filings on our XFOR SEC filings page.
What types of SEC filings does X4 Pharmaceuticals, Inc file?
Public companies like X4 Pharmaceuticals, Inc file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.